Israel China Biotechnology (ICB) Ltd (ICB) — Tangible Net Worth Ratio
Israel China Biotechnology (ICB) Ltd (ICB) has a Tangible Net Worth Ratio of 100.0% as of June 2021. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA2.55 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Israel China Biotechnology (ICB) Ltd (ICB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Israel China Biotechnology (ICB) Ltd Tangible Net Worth Ratio (2015–2020)
This chart shows how Israel China Biotechnology (ICB) Ltd's Tangible Net Worth Ratio has changed across 5 annual periods from 2015 to 2020. As of June 2021, the ratio stands at 100.0%, reflecting net assets of ILA2.55 Million with intangible assets of ILA0.00 ILA. See how many days can Israel China Biotechnology (ICB) Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below presents the year-by-year Tangible Net Worth Ratio for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Israel China Biotechnology (ICB) Ltd stock valuation.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2020 | 100.0% | ILA470.00K | ILA0.00 | ILA8.34 Million | ▲ +0.0 pp |
| 2019 | 100.0% | ILA1.89 Million | ILA0.00 | ILA11.57 Million | ▲ +0.0 pp |
| 2018 | 100.0% | ILA7.41 Million | ILA0.00 | ILA9.88 Million | ▲ +16.9 pp |
| 2016 | 83.1% | ILA1.91 Million | ILA322.00K | ILA4.06 Million | ▼ -16.9 pp |
| 2015 | 100.0% | ILA5.78 Million | ILA0.00 | ILA8.18 Million | — |